| Bioactivity | 6-Aminocaproic acid (EACA), a monoamino carboxylic acid, is a potent and orally active inhibitor of plasmin and plasminogen. 6-Aminocaproic acid is a potent antifibrinolytic agent. 6-Aminocaproic acid prevents clot lysis through the competitive binding of lysine residues on plasminogen, inhibiting plasmin formation and reducing fibrinolysis. 6-Aminocaproic acid can be used for the research of bleeding disorders[1][2]. | ||||||||||||
| Invitro | 6-Aminocaproic acid (20-180 μg/mL) inhibits fibrinolysis in plasma of Asian elephants, with an effective concentration of 61.5 μg/mL[2].6-Aminocaproic acid can be used as a hydrophobic linker to improve near-infrared fluorescence imaging and photothermal cancer therapy of PEGylated indocyanine green[4]. | ||||||||||||
| Name | 6-Aminocaproic acid | ||||||||||||
| CAS | 60-32-2 | ||||||||||||
| Formula | C6H13NO2 | ||||||||||||
| Molar Mass | 131.17 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
6-Aminocaproic acid
CAS: 60-32-2 F: C6H13NO2 W: 131.17
6-Aminocaproic acid (EACA), a monoamino carboxylic acid, is a potent and orally active inhibitor of plasmin and plasmino
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.